Can CPV get to $1 per share, page-214

There should be about another $800,000 R&D tax rebate. Problem is that > $5m has been spent and no glasshouse built, no crops tested, etc. What happened to all the grant money, the matching shareholders' funds?

COVID-19 has been beneficial to CPV shareholders. Without management swanning about the world staying in 5 star hotels, eating at fancy restaurants, exhibiting at trade shows which at best generate JVs that don't even pay for corresponding taxi fares, there should be $500,000 or so left in kitty to start new financial year.

As to why CPV has dual listed in Europe and opened sales office in Singapore when there hasn't been any data to justify commercial viability of CPV products is a mystery. It will stop the CPV directors from justifying losses by claiming the company was only engaging in R&D; they set up Singapore sales office and exhibited lots of trade shows.

The directors have done well with their "arms length" earnings. Shareholders should have invested in the other companies owned by the directors as CPV has consistently paid them very generously for legal services, admin services, corporate advice.

Other poster is right. Play the stock for the fluctuations. 10 years of "potential" and still no data to justify commercial viability is just a losing gamble for holders of the stock.